Stonebridge Capital Advisors LLC Bausch Health Companies Inc. Transaction History

Stonebridge Capital Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 23, 2023	SELL	$5.72 - $8.8 $2,860 - $4,400	-500 Reduced 13.89%	3,100 $24,000
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $5,481 - $7,137	-900 Reduced 20.0%	3,600 $22,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $3,206 - $6,447	-700 Reduced 13.46%	4,500 $31,000
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $5,648 - $18,904	-800 Reduced 13.33%	5,200 $43,000
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $128,220 - $206,280	6,000 New	6,000 $190,000
Q3 2020 Nov 18, 2020	SELL	$14.88 - $20.13 $126,108 - $170,601	-8,475 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $5,989 - $9,229	450 Added 5.61%	8,475 $155,000
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $23,364 - $54,450	1,800 Added 28.92%	8,025 $124,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $10,861 - $18,336	-575 Reduced 8.46%	6,225 $186,000
Q2 2019 Aug 15, 2019	BUY	$20.52 - $26.45 $139,536 - $179,860	6,800 New	6,800 $171,000

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.